rs377119410
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_003072.5(SMARCA4):c.3791C>A(p.Thr1264Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1264M) has been classified as Likely benign.
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.3791C>A | p.Thr1264Lys | missense_variant | Exon 27 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.3791C>A | p.Thr1264Lys | missense_variant | Exon 27 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.3791C>A | p.Thr1264Lys | missense_variant | Exon 27 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.3791C>A | p.Thr1264Lys | missense_variant | Exon 27 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643995.1 | c.3203C>A | p.Thr1068Lys | missense_variant | Exon 24 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.2435C>A | p.Thr812Lys | missense_variant | Exon 20 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000642350.1 | c.2276C>A | p.Thr759Lys | missense_variant | Exon 19 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.2144C>A | p.Thr715Lys | missense_variant | Exon 18 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000643549.1 | c.3774+266C>A | intron_variant | Intron 26 of 34 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.3774+266C>A | intron_variant | Intron 27 of 34 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.3774+266C>A | intron_variant | Intron 26 of 33 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.3774+266C>A | intron_variant | Intron 26 of 33 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.3774+266C>A | intron_variant | Intron 27 of 34 | 5 | ENSP00000464778.1 | ||||
SMARCA4 | ENST00000644065.1 | c.2499+266C>A | intron_variant | Intron 19 of 26 | ENSP00000493615.1 | |||||
SMARCA4 | ENST00000538456.4 | c.30+266C>A | intron_variant | Intron 1 of 7 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 0
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 1264 of the SMARCA4 protein (p.Thr1264Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 648940). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.T1264K variant (also known as c.3791C>A), located in coding exon 26 of the SMARCA4 gene, results from a C to A substitution at nucleotide position 3791. The threonine at codon 1264 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved on limited sequence alignment. In addition, the in silico prediction for this alteration is inconclusive. Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Based on the supporting evidence, the association of this alteration with Coffin-Siris syndrome is unknown; however, the association of this alteration with rhabdoid tumor predisposition syndrome is unlikely. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at